Mary L. Vance MD
Diabetes, Lipid Metabolism, Pituitary Disorders & Neuroendocrinology
Professor of Medicine, University VA School of Medicine
Join to view full profile
415 Ray C Hunt DrSte 2100Charlottesville, VA 22903
Phone+1 434-982-3591
Fax+1 434-924-5894
Dr. Vance is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Virginia Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1980 - 1983
Baylor University Medical CenterResidency, Internal Medicine, 1977 - 1980
Louisiana State University School of Medicine in New OrleansClass of 1977
Certifications & Licensure
VA State Medical License 1981 - 2026
TX State Medical License 1977 - 1993
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2013-2017
Clinical Trials
Publications & Presentations
PubMed
- 1 citationsRisk of new tumor, carotid stenosis, and stroke after stereotactic radiosurgery for pituitary tumor: A multicenter study of 2254 patients with imaging follow-up.Chloe Dumot, Georgios Mantziaris, Sam Dayawansa, Carson Brantley, Cheng-Chia Lee
Neuro-Oncology. 2024-12-05 - 10 citationsStereotactic radiosurgery for nonfunctioning pituitary tumor: A multicenter study of new pituitary hormone deficiency.Chloe Dumot, Georgios Mantziaris, Sam Dayawansa, Selcuk Peker, Yavuz Samanci
Neuro-Oncology. 2024-04-05 - 2 citationsSilent Corticotroph Staining Pituitary Neuroendocrine Tumors: Prognostic Significance in Radiosurgery.Georgios A Maragkos, Georgios Mantziaris, Stylianos Pikis, Tomas Chytka, Roman Liscak
Neurosurgery. 2023-12-01
Press Mentions
Pathology of Prolactinomas: Any Predictive Value?October 22nd, 2019
Grant Support
- Preoperative Bexarotene Treatment For Cushing'S DiseaseNational Center For Research Resources2010
- Clinical Trial: Effect Of Growth Hormone Treatment On Recovery From Cushing'S DINational Center For Research Resources2008–2010
- Effect Of Growth Hormone Treatment On Recovery From Cushing'S DiseaseNational Center For Research Resources2005–2007
- The Efficacy And Safety;Pegvisomant Vsasandostatin LARNational Center For Research Resources2006
- Pegvisomant;Sandostatin Lar;Pegvisomant PLUS Sandostatin LAR In AcromegalyNational Center For Research Resources2005–2006
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
